Heron Therapeutics
HRTX
HRTX
194 hedge funds and large institutions have $2.77B invested in Heron Therapeutics in 2018 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 77 increasing their positions, 61 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
9.42% less ownership
Funds ownership: 122% → 112.57% (-9.4%)
17% less capital invested
Capital invested by funds: $3.33B → $2.77B (-$565M)
27% less funds holding in top 10
Funds holding in top 10: 11 → 8 (-3)
Holders
194
Holding in Top 10
8
Calls
$22.4M
Puts
$6.67M
Top Buyers
| 1 | +$54.5M | |
| 2 | +$52.6M | |
| 3 | +$25.9M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$19.8M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$12.9M |
Top Sellers
| 1 | -$85.3M | |
| 2 | -$53.9M | |
| 3 | -$14M | |
| 4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$12.2M |
| 5 |
Renaissance Technologies
New York
|
-$8.18M |